Cellares Stock

www.cellares.com/Healthcare / Healthcare providers & servicesFounded: 2019Funding to Date: $355.75MM

Cellares, founded in 2019, is a cell therapy manufacturer that strives to develop scalable solutions to accelerate care for people living with a range of diseases. The company is the first Integrated Development and Manufacturing Organization (IDMO), and its Cell Shuttle platform aims to use automation to increase productivity at facilities that manufacture cell therapies for both autologous and allogeneic processes. Cellares is headquartered in San Francisco, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Cellares, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cellares’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cellares.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Fabian Gerlinghaus
Co-Founder & Chief Executive Officer
Omar Kurdi
Co-Founder & President
Gary Lo
Chief Financial Officer

Board Members

Justin Butler
Eclipse Ventures
Victor Tong Jr.
Decheng Capital

Frequently Asked Questions About Cellares’ Stock

Can you buy Cellares’ stock?
Cellares is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cellares’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cellares’ stock?
Yes, you can sell stock of a private company like Cellares. Forge can help you sell your Cellares stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cellares’ stock price?
Cellares is a privately held company and therefore does not have a public stock price. However, you may access Cellares’ private market stock price with Forge Data.
What is Cellares’ stock ticker symbol?
Cellares does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Cellares unveils $255M investment round with Bristol Myers among those in the fold
Wednesday, Cellares revealed a $255 million series C investment round to complete construction of its commercial-scale cell therapy manufacturing facility in Bridgewater, New Jersey. The fresh funding follows an $82 million series B round in 2021 and brings total backing in the company to $355 million.
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.